๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Disposition of oral quinine in acute falciparum malaria

โœ Scribed by W. Supanaranond; T. M. E. Davis; S. Pukrittayakamee; K. Silamut; J. Karbwang; P. Molunto; L. Chanond; N. J. White


Publisher
Springer
Year
1991
Tongue
English
Weight
422 KB
Volume
40
Category
Article
ISSN
0031-6970

No coin nor oath required. For personal study only.

โœฆ Synopsis


Plasma quinine concentrations following oral quinine sulphate 10 mg salt/kg have been measured by HPLC in 15 adult Thai patients with uncomplicated falciparum malaria. In 10 of the same patients the study was repeated in convalescence. In acute malaria plasma concentrations were approximately 50% higher than in convalescence; the mean acute peak plasma quinine concentration was 8.4 mg.l-1 compared to 5.7 mg.l-1 in convalescence. There was considerable variation in the rate of drug absorption, particularly in acute malaria. The mean time to peak plasma concentration was 5.9 h in acute malaria and 3.2 h in convalescence. The apparent clearance of oral quinine (CL/f) during the illness was 1.51 ml.kg-1.min-1, which was significantly lower than in convalescence--2.67 ml.kg-1.min-1. Estimated free quinine clearance was also lower in the acute phase: 30.6 compared to 49.0 ml.kg-1.min-1 in convalescence. Mean (SD) plasma protein binding of quinine was 94.7% in acute malaria and 92.8% in convalescence. Binding was significantly correlated with the plasma concentration of alpha 1 acid glycoprotein (r = 0.5), which was significantly higher in the acute phase; 1.48 g.l-1 compared to 1.05 g.l-1 during convalescence. Oral quinine sulphate was well absorbed in uncomplicated falciparum malaria. High blood concentrations following the administration of oral quinine in acute malaria are probably related to increased plasma protein binding, lower apparent volume of distribution, and a reduction in its systemic clearance.


๐Ÿ“œ SIMILAR VOLUMES


Pharmacokinetics of quinine and 3-hydrox
โœ Paul Newton; Duangsuda Keeratithakul; Paktiya Teja-Isavadharm; Sasithon Pukritta ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 468 KB

The plasma concentrations of quinine and its main metabolite, 3-hydroxyquinine (30HQn), were measured in 5 adult Thai patients with severe Plasmodium falciparum malaria and acute renal failure. Two patients required peritoneal dialysis but all survived. During acute renal failure plasma concentratio

Low-dose quinine for treatment of Plasmo
โœ Poul-Erik Kofoed; Francisco Lopes; Peter Johansson; Francisco Dias; Anita Sandst ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 393 KB

The recommended dose of 10 mg quinine/kg bodyweight 3 times a day for 7 days for treatment of malaria is so high that many patients experience cinchonism. We have earlier obtained good results with 7 days' treatment with 20 mg Quinimax/kg bodyweight divided into 2 daily doses. In order to identify t